| DTMC |
NIDA-CSP-1022 |
Phase 2, Double-Blind, Placebo-Controlled Trial Of Selegiline Transdermal System (STS) As An Aid For Smoking Cessation |
Elbert D. Glover, PhD, FASHA, FAAHB, FRIPH |
|
| DTMC |
NIDA-CSP-1019 |
Double-Blind, Placebo-Controlled Trial Of Selegiline Transdermal System For The Treatment Of Cocaine Dependence |
Ahmed Elkashef, M.D., Paul J. Fudala, Ph.D. |
|
| DTMC |
NIDA-CTO-0004 |
Assessment Of Potential Interactions Between Intravenous Methamphetamine And Oral Selegiline |
Thomas F. Newton, M.D. |
|
